📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor (2018)

First Author: Franklin M

Attributed to: Understanding synthetic lethality of ATR inhibitors with DDR dysregulation common in ovarian cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cam4.1724

PubMed Identifier: 30109783

Publication URI: http://europepmc.org/abstract/MED/30109783

Type: Journal Article/Review

Parent Publication: Cancer Medicine

Issue: 9

ISSN: 2045-7634